IRIS
GIANNONI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.773
AS - Asia 13.013
EU - Europa 12.318
SA - Sud America 2.842
AF - Africa 335
Continente sconosciuto - Info sul continente non disponibili 303
OC - Oceania 31
Totale 52.615
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.402
SG - Singapore 4.726
RU - Federazione Russa 3.449
IT - Italia 3.159
CN - Cina 3.133
BR - Brasile 2.225
VN - Vietnam 1.801
GB - Regno Unito 1.778
BD - Bangladesh 956
CA - Canada 938
HK - Hong Kong 922
DE - Germania 841
UA - Ucraina 627
SE - Svezia 476
FR - Francia 441
IN - India 274
DK - Danimarca 271
FI - Finlandia 269
NL - Olanda 231
MX - Messico 230
AR - Argentina 223
IE - Irlanda 195
PL - Polonia 179
IL - Israele 177
TR - Turchia 159
ID - Indonesia 138
EC - Ecuador 127
ES - Italia 114
JP - Giappone 113
IQ - Iraq 109
PK - Pakistan 109
ZA - Sudafrica 105
AT - Austria 71
CO - Colombia 63
MA - Marocco 61
UZ - Uzbekistan 60
VE - Venezuela 58
LT - Lituania 43
AE - Emirati Arabi Uniti 42
CL - Cile 42
CR - Costa Rica 42
PH - Filippine 37
MY - Malesia 35
PY - Paraguay 33
SA - Arabia Saudita 32
KE - Kenya 31
JM - Giamaica 29
TN - Tunisia 28
EG - Egitto 27
EU - Europa 27
HN - Honduras 26
NP - Nepal 26
PE - Perù 25
UY - Uruguay 23
CH - Svizzera 21
RO - Romania 21
BE - Belgio 19
DZ - Algeria 18
AU - Australia 17
JO - Giordania 17
AZ - Azerbaigian 16
NI - Nicaragua 16
TH - Thailandia 15
GT - Guatemala 14
PT - Portogallo 14
SV - El Salvador 14
BO - Bolivia 13
KG - Kirghizistan 13
KR - Corea 13
DO - Repubblica Dominicana 12
GR - Grecia 12
PS - Palestinian Territory 12
TT - Trinidad e Tobago 12
CZ - Repubblica Ceca 9
NZ - Nuova Zelanda 9
HU - Ungheria 8
PA - Panama 8
PR - Porto Rico 8
TW - Taiwan 8
BG - Bulgaria 7
ET - Etiopia 7
KZ - Kazakistan 7
LY - Libia 7
OM - Oman 7
SI - Slovenia 7
AO - Angola 6
BB - Barbados 6
BH - Bahrain 6
CI - Costa d'Avorio 6
GE - Georgia 6
GY - Guiana 6
IR - Iran 6
MD - Moldavia 6
MG - Madagascar 6
QA - Qatar 6
AL - Albania 5
CG - Congo 5
GD - Grenada 5
HR - Croazia 5
MT - Malta 5
Totale 52.224
Salva come PNG Salva come JPEG
Città #
Dallas 3.746
Singapore 2.365
Ashburn 1.804
San Jose 1.701
Beijing 1.245
Council Bluffs 957
Southend 907
Hong Kong 802
Chandler 734
Los Angeles 693
Moscow 595
Fairfield 585
Houston 567
Ho Chi Minh City 535
Woodbridge 471
New York 464
Chicago 456
Milan 445
San Mateo 436
Ann Arbor 422
Falls Church 406
Seattle 376
Hanoi 364
Cambridge 334
Jacksonville 334
Wilmington 326
Santa Clara 322
Rome 321
The Dalles 304
Buffalo 269
Ottawa 259
São Paulo 249
Boardman 238
Lauterbourg 224
Phoenix 224
Hefei 215
Dearborn 214
Dublin 187
Pisa 184
Salt Lake City 184
Portsmouth 170
Stevenage 164
Beauharnois 163
Orem 157
Warsaw 154
Tel Aviv 152
Dong Ket 147
Munich 146
Montreal 142
Helsinki 141
London 141
Lawrence 133
Brooklyn 127
Mexico City 113
Atlanta 112
Toronto 109
Denver 103
Tokyo 99
Florence 98
Stockholm 91
Frankfurt am Main 88
Chennai 85
Poplar 85
Tampa 84
Elk Grove Village 75
Istanbul 75
Amsterdam 74
Da Nang 72
Montréal 72
Naples 72
Nuremberg 72
Johannesburg 71
Rio de Janeiro 71
San Diego 69
Figino 67
Haiphong 61
Boston 59
Bologna 55
Tashkent 55
Turin 55
Fremont 53
Columbus 52
San Francisco 52
Manchester 50
Guayaquil 48
Ankara 47
Washington 45
Brasília 44
Biên Hòa 43
Miami 42
Mumbai 41
Turku 41
Lappeenranta 40
Redwood City 40
Belo Horizonte 39
Genoa 39
Dongguan 37
Paris 37
Quito 37
Lancaster 36
Totale 30.406
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.727
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 642
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 531
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 466
A simple echocardiographic score to rule out cardiac amyloidosis 431
A simple echocardiographic score to rule out cardiac amyloidosis 411
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 410
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 379
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 370
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 363
Central sleep apnea and cardiovascular disease state-of-the-art 361
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 361
[Central apneas and cardiovascular diseases] 357
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 352
Etiology, clinical presentation, and management of left main coronary artery aneurysms 348
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 348
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 345
Prediction of the chemoreflex gain by common clinical variables in heart failure 345
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 343
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 341
Treating chemoreflex in heart failure: modulation or demolition? 335
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 332
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 332
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 331
Adrenergic activation in heart failure: blockade or rebalance? 324
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 320
Eligibility for vericiguat in a real‐world, contemporary heart failure population 320
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 318
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 317
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 315
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 314
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential 313
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 311
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 310
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 308
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 307
Screening the health status of people working in a university 305
How to take arms against central apneas in heart failure 300
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 297
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 295
Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function 294
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 292
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 291
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 288
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 287
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 286
A Novel Homozygous Mutation of the Desmoplakin Gene With Biventricular Arrhythmogenic Cardiomyopathy 285
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 281
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 279
Models of BOLD Signal Change in Breath Hold Studies and CO2 Challenges: Methodological Issues and Interpretation 279
APAP therapy does not improve impaired sleep quality and sympatho-vagal balance: a randomized trial in patients with obstructive sleep apnea and systolic heart failure 279
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 278
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 278
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis 276
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 274
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 273
Effects of nasal high flow on sympathovagal balance, sleep, and sleep-related breathing in patients with precapillary pulmonary hypertension 273
Improved survival in limited scleroderma-related pulmonary artery hypertension 272
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones 271
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 270
A Novel Workflow for Electrophysiology Studies in Patients with Brugada Syndrome 268
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 268
Valve disease in cardiac amyloidosis: an echocardiographic score 267
B-type natriuretic peptide secretion following scuba diving 267
Correlational analysis of electroencephalographic and end-tidal carbon dioxide signals during breath-hold exercise 267
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 264
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 263
Prognostic value of right ventricular refractory period heterogeneity in Type-1 Brugada electrocardiographic pattern 263
Mapping dependencies of BOLD signal change to end-tidal CO2: Linear and nonlinear modeling, and effect of physiological noise correction 260
A scoping review of machine learning models to predict risk of falls in elders, without using sensor data 259
null 258
Chemoreflex and Baroreflex Sensitivity Hold a Strong Prognostic Value in Chronic Heart Failure 258
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 258
null 258
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 257
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation 257
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 256
Renin profiling predicts neurohormonal response to sacubitril/valsartan 256
An atypical case of cardiac amyloidosis. 255
Autonomic and respiratory consequences of altered chemoreflex function: clinical and therapeutic implications in cardiovascular diseases 254
Role of Imaging in Cardiomyopathies 253
null 253
Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction 252
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 251
High-risk NSTEMI due to subclavian artery atherothrombosis in a prior coronary artery bypass graft patient 250
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 250
Effects of hyperventilation length on muscle sympathetic nerve activity in healthy humans simulating periodic breathing 250
Changes in chemoreflex characteristics following acetazolamide administration in patients with chronic heart failure and Cheyne Stokes respiration 249
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 249
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. 248
Inspiratory muscle dysfunction and restrictive lung function impairment in congenital heart disease: Association with immune inflammatory response and exercise intolerance 247
Ld-EEG Effective Brain Connectivity in Patients With Cheyne-Stokes Respiration 247
Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. 244
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry 243
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 242
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 241
Impact of Simulated Hyperventilation and Periodic Breathing on Sympatho-Vagal Balance and Hemodynamics in Patients with and without Heart Failure 241
On the Use of Linear-Modelling-based Algorithms for Physiological Noise Correction in fMRI Studies of the Central Breathing Control 240
Cardiac Amyloidosis: How Its Epidemiology is Changing 239
Breath-hold task induces temporal heterogeneity in electroencephalographic regional field power in healthy subjects 239
Totale 31.282
Salva come PNG Salva come JPEG
Categoria #
all - tutte 257.493
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 257.493
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.686 0 0 0 278 71 43 239 431 151 247 55 171
2022/20231.643 133 154 83 209 220 243 17 143 253 32 81 75
2023/20241.162 107 34 280 90 37 88 80 49 30 39 39 289
2024/202510.624 65 80 466 207 596 585 1.383 2.351 871 919 1.973 1.128
2025/202625.926 1.343 3.988 2.900 3.612 2.928 1.598 2.381 1.034 1.384 1.546 1.706 1.506
2026/20273.983 752 799 1.458 974 0 0 0 0 0 0 0 0
Totale 52.615